Bryan Smith
General Counsel
Eledon Pharmaceuticals, Inc. (ELDN)Equibles does not estimate personal net worth.
About Bryan Smith
Bryan Smith is recorded as General Counsel at Eledon Pharmaceuticals, Inc. (ELDN). The newest filing on record that lists Bryan Smith as General Counsel at Eledon Pharmaceuticals, Inc. (ELDN) is dated April 30, 2026. The proxy statement of Eledon Pharmaceuticals, Inc. reports total compensation of $1,682,736 for Bryan Smith in fiscal 2021, including a base salary of $276,923. Eledon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eledon Pharmaceuticals, Inc. includes David-Alexandre "DA" C. Gros, M.D. (CEO and Board Member), David-Alexandre C. Gros (CEO and Board Member), David-Alexandre C. Gros, M.D. (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Eledon Pharmaceuticals, Inc.
- David-Alexandre "DA" C. Gros, M.D. CEO, Board Member
- David-Alexandre C. Gros CEO, Board Member
- David-Alexandre C. Gros, M.D. CEO, Board Member
- David-Alexandre Gros CEO, Board Member
- Jon Kuwahara CEO
- Paul Little CFO, Chief Accounting Officer
- Allan D. Kirk Board Member
- Allan Douglas Kirk, MD, PhD, FACS Board Member
- James Robinson Board Member
- Jan Hillson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | General Counsel, Corporate Secretary and Compliance Officer | $276,923 | $1,682,736 |
Recent activity
No call appearances or filed executive changes recorded yet.